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RESE ARCH ARTICLE

Cadmium opens GluK2 kainate receptors with
cysteine substitutions at the M3 helix bundle crossing
Timothy J. Wilding and James E. Huettner

Kainate receptors are ligand-gated ion channels that have two major roles in the central nervous system: they mediate
a postsynaptic component of excitatory neurotransmission at some glutamatergic synapses and modulate transmitter
release at both excitatory and inhibitory synapses. Accumulating evidence implicates kainate receptors in a variety of
neuropathologies, including epilepsy, psychiatric disorders, developmental delay, and cognitive impairment. Here, to
gain a deeper understanding of the conformational changes associated with agonist binding and channel opening, we
generate a series of Cys substitutions in the GluK2 kainate receptor subunit, focusing on the M3 helices that line the ion
pore and form the bundle-crossing gate at the extracellular mouth of the channel. Exposure to 50 µM Cd produces direct
activation of homomeric mutant channels bearing Cys substitutions in (A657C), or adjacent to (L659C), the conserved SYT
ANLAAF motif. Activation by Cd is occluded by modification with 2-aminoethyl MTS (MTSEA), indicating that Cd binds
directly and specifically to the substituted cysteines. Cd potency for the A657C mutation (EC50 = 10 µM) suggests that
binding involves at least two coordinating residues, whereas weaker Cd potency for L659C (EC50 = 2 mM) implies that
activation does not require tight coordination by multiple side chains for this substitution. Experiments with heteromeric
and chimeric channels indicate that activation by Cd requires Cys substitution at only two of the four subunits within a
tetrameric receptor and that activation is similar for substitution within subunits in either the A/C or B/D conformations.
We develop simple kinetic models for the A657C substitution that reproduce several features of Cd activation as well as
the low-affinity inhibition observed at higher Cd concentrations (5–20 mM). Together, these results demonstrate rapid and
reversible channel activation, independent of agonist site occupancy, upon Cd binding to Cys side chains at two specific
locations along the GluK2 inner helix.

Introduction

Ionotropic glutamate receptors (iGluRs) are tetrameric proteins in the pore loop superfamily of ion channels that also includes voltage-gated sodium, calcium, and potassium channels
as well as cyclic nucleotide–gated channels, TRP channels, and
others (Hille, 2001). Structural analysis of iGluRs has revealed
a modular organization with each subunit in the tetramer contributing to four distinct domains (Traynelis et al., 2010). The
amino terminal domain (ATD) and ligand-binding domain (LBD)
are extracellular. The transmembrane domain (TMD) forms the
ion-conducting pore (Huettner, 2015), and the carboxy-terminal
domain (CTD) is intracellular. In the closed state, tight association of inner helices at the bundle crossing occludes the conduction pathway, denying ions passage through the pore (Doyle et
al., 1998; Sobolevsky et al., 2009). Conformational changes in the
LBD contingent on agonist binding (Mayer, 2017; Twomey and
Sobolevsky, 2018) open the channels by pulling on short linkers

that splay apart and deform the inner (M3) helix bundle to remove the occlusion and provide a route for water and ions into
the central cavity (Chen et al., 2017; Twomey et al., 2017).
Despite limited overall sequence identity among iGluR subtypes (Traynelis et al., 2010), the bundle-crossing occlusion zone
near the extracellular end of M3 comprises the longest identical
segment across the different subunits. Throughout the paper we
will use the numbering system in Fig. 1 A to refer to homologous
M3 positions relative to the first conserved residue (S = 1) of the
nine–amino acid SYTANLAAF motif. Initial evidence that the M3
helix plays a role in glutamate receptor gating came from analysis
of the Lurcher mutant mouse in which an A to T point mutation
at position 8 of this motif (A8T) in the orphan delta subunit results in constitutive channel activity (Zuo et al., 1997; Wollmuth
et al., 2000). Subsequent work showed that substitution of the
homologous A8 alanine residue in AMPA, kainate, and NMDA re-
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ceptors increases apparent affinity for agonists, reduces desensitization, slows the rate of receptor deactivation, and allows some
degree of constitutive channel opening in the absence of added
agonist (Kohda et al., 2000; Taverna et al., 2000; Schwarz et al.,
2001; Klein and Howe, 2004; Schmid et al., 2007). Interest in how
this segment contributes to channel operation has been heightened by growing evidence that the LBD–TMD linkers and extracellular ends of M1, M3, and M4 serve as targets for a number
of iGluR subtype-selective allosteric modulators (Yelshanskaya
et al., 2016; Wang et al., 2017; Perszyk et al., 2018). In addition,
recent studies have identified a spectrum of neuropathologies
that can result from missense mutations at, or near, the Lurcher
site of several human iGluR subunits (Li et al., 2016; FernándezMarmiesse et al., 2018; Fry et al., 2018), including the kainate
receptor subunit GluK2 (Guzmán et al., 2017). This accumulating
evidence has spurred recent efforts to understand how spontaneous and engineered mutations in the bundle crossing and LBD–
TMD linker segments affect iGluR function (Alsaloum et al., 2016;
Yelshanskaya et al., 2017; Ladislav et al., 2018).
One approach to evaluating structural changes associated
with channel gating involves cysteine scanning mutagenesis in which each amino acid in a protein segment is individually replaced with cysteine residues and the resulting set of
mutant constructs tested for accessibility to modification by
cysteine-reactive MTS reagents (Akabas, 2015). Differences
in accessibility to MTS reagent modification, or in the rate of
modification, between different gating states of the channel
can thus provide information about the conformational changes
that underlie the gating state transitions. In the course of these
studies, it has sometimes been observed that cysteines substituted at specific locations allow fortuitous coordination of metal
ions that can stabilize a specific conformational state (Liu et al.,
1997; Holmgren et al., 1998; Zhou et al., 2015). In the case of iGluRs, a coordination site for copper ions that locks channels in
the closed configuration can be formed by cysteine substitution
at two distinct locations along the inner helix of NMDA receptor GluN1 (T3C) and GluN2 (L-1C) subunits (Sobolevsky et al.,
2002). Both sites must be substituted in a heteromeric receptor
in order for copper to bind, and recovery is slow without exposure to reducing agents (Sobolevsky et al., 2002). In addition,
coapplication of Cd was shown to inhibit agonist-evoked current
flow through homomeric GluA1 AMPA receptors with L-4C or
A7C substitutions (Sobolevsky et al., 2004). Exposure to Cd in
the absence of agonist had little effect, but recovery from inhibition was independent of agonist, suggesting that Cd did not
become trapped when cells were switched to agonist-free solutions (Sobolevsky et al., 2004).
In the present study, we have examined the action of Cd on
homomeric GluK2 kainate receptors with cysteine substitutions
from W-8C to V12C near the extracellular end of the M3 helix.
Our results show that exposure to Cd alone directly activates
receptors with substitutions at two specific positions (A8C and
L10C) within the bundle crossing occlusion zone. Furthermore,
using chimeric subunits that combine the extracellular ATD
and LBD from NMDA receptors with the GluK2 TMD and CTD
(Wilding et al., 2014), we find that activation by Cd only requires
cysteine substitution in two of the four subunits within a tetramWilding and Huettner
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Figure 1. The M3 helix sequence conservation. (A) Alignment of ionotropic
glutamate receptor subunit inner helix (M3) sequences. Numbers to the right
denote position of the final residue from the N-terminal methionine. Homologous positions are numbered above the sequences relative to the first conserved residue (S = 1) of the nine–amino acid SYTANLAAF motif. Yellow highlights identical residues, and gray highlights positions of nonidentity within
the GluN2 and GluK4/5 subfamilies. The A8 Lurcher site is marked with a red
asterisk. In the closed conformation, the M3 helix extends to approximately
+17 and +12 in the A/C and B/D configurations, respectively, as indicated by
gray cylinders above the sequence. A horizontal line below the sequence
indicates the closed conformation bundle crossing occlusion. (B) The GluK2
homology model based on the homomeric GluA2 AMPA receptor closed state
x-ray structure. The A/C configurations are shown in green and blue; B/D
configurations are shown in red and yellow. The bottom right box shows an
expanded view of the linkage zone between the LBD and TMD of the B and D
subunits. The top right box shows B and D subunit M3 helices with A8C and
WT A7 and L10 side chains displayed.

eric receptor and that susceptibility to activation by Cd is essentially equivalent for cysteine substitutions to subunits in either
the A/C or B/D conformation (Fig. 1).

Materials and methods

Complementary DNA (cDNA) constructs, cell culture,
and transfection
WT GluK2(R) cDNA provided by Steve Heinemann (Salk Institute, La Jolla, CA) was subcloned into pcDNA3 for expression in
human embryonic kidney (HEK293) cells. Conversion to glutamine at the Q/R site and cysteine substitutions along the GluK2
M3 helix were prepared as described (Wilding et al., 2008) using
the QuickChange XL site-directed mutagenesis kit (Agilent Technologies). Additional subunit cDNAs provided by Mark Mayer
(National Institutes of Health, Bethesda, MD), Peter Seeburg
(Max Planck Institute, Heidelberg, Germany), and Stefano Vicini
(Georgetown University, Washington, DC) were used to construct
chimeric subunits as previously described (Wilding et al., 2014).
Residue substitutions in chimeric subunits were generated by
PCR. All constructs were verified by sequencing in the WashingJournal of General Physiology
https://doi.org/10.1085/jgp.201812234
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Figure 2. Cd inhibits WT GluK2(Q) and GluK2(R). (A) Whole-cell currents
evoked by 10 µM kainate in an HEK cell transfected with GluK2(R). Kainate
was applied as indicated by the open bars. Solid bars indicate coapplication
of Cd at 10, 50, 100, and 500 µM and 1 and 5 mM. Holding potential is −80
mV. (B) Current (mean ± SEM) recorded during Cd coapplication plotted as
a fraction of control current immediately before Cd exposure (five cells for Q
and four cells for R). Smooth curves are the best fit of I/Icontrol = 100/(1 + ([Cd]/
IC50)n), where IC50 is the concentration that produced half-maximal inhibition
and n is the slope factor. (C) Outward current evoked by kainate in a different
cell held at +40 mV was inhibited by brief exposure to 5 mM Cd as indicated
by the solid bar.

ton University protein and nucleic acid chemistry laboratory.
The HEK293 cells at ∼60% confluence were transfected with 1–3
µg of subunit cDNA using lipofectamine 2000 (Thermo Fisher
Scientific). Coexpression of GFP from a second plasmid was used
to identify transfected cells. On the day after transfection, cells
were dissociated with mild protease treatment and replated at
low density on nitrocellulose-treated 35-mm dishes (Wilding et
al., 2008). Physiological recordings were obtained from green
fluorescent cells 24–48 h after replating.
Electrophysiology
Cultures were perfused with Tyrode’s solution (in mM): 150 NaCl,
4 KCl, 2 MgCl2, 2 CaCl2, 10 glucose, 10 HEPES, pH 7.4, with NaOH.
Whole-cell electrodes were filled with internal solution (in mM):
140 Cs-glucuronate, 10 EGTA, 5 CsCl, 5 MgCl2, 5 ATP, 1 GTP, 10
HEPES, pH adjusted to 7.4, with CsOH. Currents were recorded
with an Axopatch 200A amplifier controlled by pClamp software
(Molecular Devices). Agonist and Cd applications were made in
control extracellular solution (160 mM NaCl, 2 mM CaCl2 and
10 mM HEPES, pH 7.4, with NaOH) delivered by gravity-driven
local perfusion from an eight-barreled pipette positioned near
Wilding and Huettner
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Figure 3. Cd activates kainate receptors with inner helix cysteine substitutions. (A) Whole-cell current evoked by 10 µM kainate (open bar) and
no effect of 50 µM Cd alone (red bars) in an HEK cell transfected with WT
GluK2(Q). (B) Currents evoked by exposure to kainate and Cd in a different cell
transfected with GluK2(Q) A8C plotted at the same current scale. (C) Coapplication of 50 µM Cd and 10 µM kainate compared with Cd alone. In A–C,
holding potential is −80 mV. (D and E) Current evoked by 10 µM kainate or
50 µM Cd during voltage ramps from −150 to +120 mV. (F) Current evoked by
50 µM Cd alone as a fraction of current evoked by 10 µM kainate alone (mean
± SEM, 4–114 cells per construct) for GluK2(Q) (open bars) and GluK2(R) (solid
bars) WT or mutant, with Cys substitution at each position from W641C (−8)
to V661C (+12). Crosses denote positions where exposure to either kainate
or Cd failed to evoke any change in holding current. Symbols indicate current
ratios significantly greater than (*) or less than (#) WT (P < 0.05, ANOVA on
ranks, post hoc Dunn’s test). (G) Current evoked by coapplication of Cd and
kainate as a fraction of kainate alone (4–21 cells per construct).

the recorded cell (time constant for solution exchange ∼50–100
ms). All measurements were made relative to holding current
in the control solution. Current–voltage (I-V) relations were
generated and analyzed from triangle wave ramps as described
(Lopez et al., 2013).
Journal of General Physiology
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when current during exposure to Cd was less than the holding
current in control solution. Steady-state currents evoked by Cd
were normalized to the maximal Cd response and fit with the following equation: I/Imax = (1/(1 + (EC50/[Cd])n))/(1 + ([Cd]/IC50)b),
where Imax is the maximal current evoked by Cd; EC50 and IC50
are the Cd concentrations producing half-maximal activation
and inhibition, respectively; and n and b are the slope factors for
activation and inhibition.
Concentration dependence for chimeric subunits exhibiting
both activation and inhibition by Cd was fit with I/Imax = m + ((1/
(1 + (EC50/[Cd])n) − m)/(1 + ([Cd]/IC50)b)), where EC50 and IC50 are
the half-maximal concentrations for activation and inhibition,
respectively; n and b are the slope factors or Hill coefficients for
activation and inhibition; and m is the minimum current baseline. Coupling energies were calculated from EC50 values for double mutant cycles as follows (Kash et al., 2003; Gleitsman et al.,
2008; Venkatachalan and Czajkowski, 2008):
Ω(
 ΔΔG)
   = − RT ln [ _______________________
    
    ].
( EC  50 wt * EC  50 double mutant) 
( EC  50 mutant 1 * EC  50 mutant 2) 

Figure 4. Concentration dependence of Cd activation. (A) Whole-cell currents evoked by 500, 50, 5, and 0.5 µM Cd alone in an HEK cell transfected
with GluK2(Q) A8C. Inset shows exponential fits to the onset (red) and recovery (blue) phases of current evoked by 50 µM Cd shown on an expanded time
scale. Holding potential is −80 mV. (B) Onset and recovery of low-affinity
inhibition during exposure to 20 and 5 mM Cd in a different cell transfected
with GluK2(Q) A8C. (C) Plot of steady-state current (mean ± SEM) as a fraction
of the maximal Cd-evoked response. Smooth curve is the best simultaneous
fit of I/Imax = (m/(1 + (EC50/[Cd])n))/(1 + ([Cd]/IC50)b) to the data for A8C substitution of both GluK2(Q) and GluK2(R), where EC50 = 7.3 ± 1.4 µM and IC50 =
25 ± 5.4 mM are the concentrations for half-maximal activation and inhibition,
respectively; n = 1.6 ± 0.4 and b = 1.3 ± 0.4 are the slope factors; and m = 0.86
± 0.03 is the maximal steady-state current. Individual fits to Q (11 cells) and
R (12 cells) data sets were not statistically superior by F test. Cd activated
GluK2(Q) L10C with weaker potency (EC50 = 1.8 ± 0.3 mM, n = 1.2 ± 0.2; IC50 =
26 ± 7.1 mM, b = 1.9 ± 0.5; m set to 1; 12 cells).

Analysis
For concentration–inhibition experiments, the current recorded
during exposure to agonist and Cd was plotted as a fraction of
control current evoked by agonist alone. Concentration–inhibition results were fit with the following equation:
I / I  control  = m + (1 − m ) / (1 + ([Cd]  / IC  50)  n),
where IC50 is the Cd concentration producing half-maximal inhibition, n is the slope factor, and m is a baseline adjustment used
Wilding and Huettner
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Unitary conductance was estimated as described previously
(Wilding et al., 2008; Lopez et al., 2013) from plots of current
variance versus mean current using data filtered at 2 kHz (−3 dB,
four-pole Bessel) and digitized at 10 kHz during slow applications
of agonist or Cd. Variance was calculated for 100-ms intervals
after subtracting a straight line fit to correct for steady amplitude changes (Bean et al., 1990). When open probability (Po)
is low (∼0.2 or less), the variance versus mean plot is approximately linear with slope equal to the unitary current (Bean et
al., 1990; Lingle, 2006). For Po > 0.2, the relationship of variance
(σ2) to mean current (I) is parabolic: σ2 = i * I – I2 /N, where i is
the estimated unitary current, and N is the estimated number
of channels (Sigworth, 1980). Maximal Po was estimated from
Po = Imax/(i * N).
Results are reported as mean ± SEM, and significance was
assigned for P < 0.05. One-way and two-way ANOVA and t tests
were performed with SigmaStat (Systat Software). Curve fits
using different numbers of parameters were evaluated by the
ratio of residual variance test, F statistic (Swartz et al., 1992).
Modeling
We used Modeller version 9.18 (Eswar et al., 2008) with twofold symmetry constraints for the A/C and B/D conformations
to model GluK2(R) A8C on the homomeric GluA2 open state
structure (PDB accession no. 5WEO) from the Sobolevsky laboratory (Twomey et al., 2017). Structures are displayed with
PyMol. Kinetic model simulations were performed in Excel by
numerical integration of entry and exit rate equations for each
postulated state.
Online supplemental material
Fig. S1 shows Cd activation of GluK2(Q) A8C receptors that include a second mutation in the LBD that reduces agonist potency
(Mah et al., 2005). Fig. S2 illustrates inhibition of GluK2 A8S, T,
Y, or F by increasing concentrations of Cd. Fig. S3 shows kinetic
model simulations that reproduce several features observed for
activation and inhibition of receptors with A8C substitutions to
Journal of General Physiology
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Table 1. Half-maximal concentrations for Cd activation and inhibition
Construct

EC50 (µM)

Slope, n

IC50 (mM)

Slope, b

Cells (no.)

K2(Q) WT (KA-evoked)

0.89 ± 0.08

1.1 ± 0.1

5

K2(R) WT (KA-evoked)

0.25 ± 0.04

1.0 ± 0.1

4

K2(Q&R) A8C

7.3 ± 1.4

1.6 ± 0.4

25 ± 5.4

1.3 ± 0.4

23

K2(Q) L10C

1,800 ± 300

1.2 ± 0.2

26 ± 7.1

1.9 ± 0.5

12

N1/K2 A8C + N2B/K2 A8C

5.6 ± 1.7

0.9 ± 0.1

1.1 ± 0.2

1.8 ± 0.4

21

N1/K2 A8C + N2B/K2

47 ± 8

1.0 ± 0.2

13 ± 10

0.9 ± 0.4

14

N1/K2 + N2B/K2 A8C

27 ± 9

0.9 ± 0.1

1.1 ± 0.2

1.8 ± 0.4

14

one or both chimeric subunit. Table S1 provides a summary of
parameters derived from these simulations.

Results

Cd inhibits WT GluK2(Q) and GluK2(R)
Previous work showed that WT native and recombinant kainate
receptors are potently inhibited by the trivalent ions La and Gd
with an IC50 of ∼3 µM (Huettner et al., 1998). In contrast, divalent cations including Ni, Co, Cu, Cd, and Zn have a substantially
weaker inhibitory effect on WT kainate receptors, typically
causing <50% inhibition at 100 µM (Huettner et al., 1998; Mott
et al., 2008; Veran et al., 2012). Before evaluating the effect of
Cd on Cys substitution mutants, we determined the concentration dependence of inhibition at homomeric recombinant
kainate receptors expressed in HEK293 cells after transfection
of cDNA encoding WT GluK2. As shown in Fig. 2, exposure to
Cd produced dose-dependent inhibition of whole-cell currents
mediated by homomeric GluK2 with either glutamine (Q) or
arginine (R) at the Q/R editing site. Average current evoked by
10 µM kainate was −2.0 ± 0.9 nA (R) and −2.8 ± 0.5 nA (Q), and
inhibition by Cd was somewhat more potent at GluK2(R) than at
GluK2(Q) with half-maximal values of 250 ± 38 µM and 890 ±
83 µM, respectively (five cells for Q and four cells for R). In a few
cells, we also tested for possible voltage dependence of Cd inhibi-

tion by coapplication of Cd and kainate at a holding potential of
+40 mV where current flows outward through kainate receptor
channels. As shown in Fig. 2 C, Cd coapplication produced essentially equivalent inhibition at positive holding potentials as was
observed at −80 mV (Fig. 2, A and B), indicating a lack of voltage
dependence and suggesting that Cd binding responsible for inhibition does not occur within the conduction pathway (Huettner
et al., 1998; Mott et al., 2008). In addition, exposure to 50 µM
Cd alone caused no significant change in the holding current recorded from untransfected cells or in cells transfected with WT
GluK2(Q) or GluK2(R) (Fig. 3 A).
Cd activates GluK2(Q) and GluK2(R) with Cys substitutions at
specific residues
Previous studies have analyzed NMDA (Beck et al., 1999; Jones et
al., 2002; Yuan et al., 2005; Sobolevsky et al., 2007; Chang and
Kuo, 2008) and AMPA (Sobolevsky et al., 2004) receptors with
Cys substitutions in the M3 transmembrane helix and linker to
the S2 extracellular segment. To test for commonalities among
iGluRs, we generated a series of point mutations along the M3
helix of both edited (R) and unedited (Q) GluK2 kainate receptor
subunits, scanning from W641C (−8) to V661C (+12; Fig. 1). Homomeric receptors with Cys substitutions at most locations were
functional when expressed by transient transfection in HEK293
cells as determined by activation of whole-cell current during

Table 2. Time constants for Cd activation and inhibition
Construct

Activation (s)

Cells (no.) [Cd]

Tau on

Tau off

0.81 ± 0.06

8.41 ± 1.07

94

50 µM

GluK2 WT (KA-evoked)
GluK2 A8C

0.10 ± 0.01

9.91 ± 3.10

19

20 mM

K2(Q) L10C

0.71 ± 0.15

1.52 ± 0.25

16

1 mM

N1/K2 A8C + N2B/K2 A8C

0.90 ± 0.23

5.95 ± 0.91

35

50 µM

0.10 ± 0.01

8.68 ± 2.73

11

5 mM

0.88 ± 0.13

2.91 ± 0.63

30

50 µM

0.11 ± 0.02

1.87 ± 0.12

13

5 mM

0.97 ± 0.17

3.24 ± 0.60

33

50 µM

0.09 ± 0.02

3.91 ± 0.87

10

5 mM

N1/K2 A8C + N2B/K2
N1/K2 + N2B/K2 A8C

Wilding and Huettner
Cd activates Cys-substituted kainate receptors

Inhibition (s)

Cells (no.) [Cd]

Tau on

Tau off

0.51 ± 0.10

2.49 ± 0.48

8

5 mM

0.33 ± 0.04

0.60 ± 0.07

19

20 mM

0.39 ± 0.05

1.12 ± 0.13

11

5 mM

0.37 ± 0.05

0.67 ± 0.06

13

5 mM

0.22 ± 0.02

0.66 ± 0.06

10

5 mM

Journal of General Physiology
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Figure 5. The M3 Cys substitutions increase agonist potency, and Cd
coapplication has a differential effect on L10C versus A8C. (A) Whole-cell
currents evoked by decreasing concentrations of kainate (open bars) from
10 µM to 2.5 nM in an HEK cell transfected with GluK2(Q) L10C. (B) In a different cell, the same agonist concentrations were applied together with 50 µM
Cd (cyan bars). Note the increased responses to low doses. (C) Plots of current
evoked by kainate (mean ± SEM) normalized to the maximal response for
each condition. Smooth curve is the best fit of I/Imax = 1/(1 + (EC50/[kainate])
n), where EC is the concentration for half-maximal activation and n is the
50
slope factor. Activation of WT receptors is half-maximal at 1.5 µM (data taken
from Wilding et al., 2005). Homomeric M3 A8C or L10C substitution increased
kainate potency by ∼12.5-fold. Individual fits to the results for K2(Q) A8C (5
cells), K2(R) A8C (3 cells), and K2(Q) L10C (10 cells) were not significantly better than the simultaneous fit to all three data sets with EC50 = 120 ± 9 nM and
n = 0.8 ± 0.04. Coapplication of 50 µM Cd to K2(Q) L10C (nine cells) produced
an additional increase in apparent agonist potency of ∼4.5-fold (EC50 = 26 ±
3 nM), whereas agonist potency was unchanged with coapplication of 0.5 µM
Cd to K2(Q) A8C (nine cells).

exposure to 10 µM kainate. Only the A4C and L6C mutants failed
to function in both the Q and R form, whereas the S0C and T11C
substitutions were functional in the Q but not the R form. In addition to kainate, each of the Cys substitution mutants were tested
with exposure to 50 µM Cd alone (Fig. 3, B, C, and F) and 50 µM
Cd together with 10 µM kainate (Fig. 3, C and G). Consistent with
our results for WT receptors (Figs. 2 and 3 A), Cd had little or no
effect when applied alone and caused modest (∼10–40%) inhibition of current evoked by kainate (Huettner et al., 1998) in cells
Wilding and Huettner
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transfected with most of the mutant constructs (Fig. 3, F and G).
However, exposure to Cd produced substantially different effects
for receptors with Cys substitutions at a few specific M3 locations. In particular, exposure to Cd alone significantly reduced
the holding current in cells expressing GluK2 subunits with A7C
substitution (Fig. 3 F) and activated large currents in cells transfected with A8C or L10C substitution mutants (Fig. 3).
For receptors with A8C or L10C substitutions, the currents activated by kainate or by Cd alone displayed similar I-V relations
(Fig. 3, D and E). As for WT GluK2(Q) and GluK2(R), the I-V relations recorded for kainate and for Cd alone in cells expressing
homomeric GluK2(Q)A8C (Fig. 3 D) or L10C showed prominent
rectification, owing to pore block by cytoplasmic polyamines
(Traynelis et al., 2010). In contrast, the I-V relations were nearly
linear in cells transfected with the A8C (Fig. 3 E) or L10C mutations of GluK2(R), which resists polyamine block (Traynelis et
al., 2010). Together, these results provide strong evidence that
currents evoked by exposure to Cd arise from direct activation
of mutant channels and not from some indirect effect enabled by
mutant subunit expression. Moreover, the rectification observed
for unedited (Q) receptors demonstrates that Cys substitution
at A8 or L10, as well as Cd activation of mutant receptors, does
not perturb the elements required for polyamine block, as can
occur with M3 residue substitutions closer to the central cavity
(Wilding et al., 2010).
Bar plots in Fig. 3, F and G, summarize the action of 50 µM
Cd alone or together with 10 µM kainate on the series of M3 Cys
substitutions. On average, for the A8C substitution, the current
evoked by Cd was similar in amplitude to current elicited by kainate plus Cd, suggesting that 50 µM Cd alone achieves nearly
maximal activation. By contrast, for the L10C substitution, currents evoked by coapplication of Cd and kainate (Fig. 3 G) were
substantially larger on average than the sum of currents activated by Cd alone and kainate alone (Fig. 3 F), suggesting synergy between Cd and kainate in promoting channel activation
for this substitution.
To determine the concentration dependence of Cd activation,
we recorded currents evoked by 0.5 µM to 20 mM Cd in cells
transfected with the A8C substitution in GluK2(Q) or GluK2(R) or
with the GluK2(Q) L10C mutant. As shown in Fig. 4, Cd activated
both the edited (R) and unedited (Q) forms of the A8C substitution mutant with half-maximal potency of ∼10 µM (Table 1).
Separate fits to the data points for Q and R isoforms were not statistically superior to the simultaneous fit of both datasets shown
in Fig. 4 C (F test, P > 0.05). A second measure of Cd affinity came
from exponential fits to the onset (τon) and recovery (τoff ) phases
of currents evoked by 50 µM Cd (Fig. 4 A, inset, and Table 2). For
the simplest model in which activation results from binding a
single Cd: Kd = τon * [Cd]/(τoff − τon), where the dissociation constant (Kd) is estimated to be 11.2 ± 1.3 µM (87 cells). The potency
for Cd activation was substantially weaker for the L10C than the
A8C substitution mutant of GluK2, as judged either by the higher
L10C mutant Cd EC50 of 1.8 ± 0.3 mM (Fig. 4 C) or the Kd of 1.7 ±
0.7 mM (16 cells) estimated from onset and recovery time constants of currents evoked by 1 mM Cd. At the highest Cd doses
tested, homomeric channels with either A8C or L10C substitutions exhibited partial inhibition of steady-state currents (Fig. 4,
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Figure 6. Synergistic activation by Cd and kainate at
GluK2 L10C. (A and B) Whole-cell currents evoked by Cd
alone (red bars), 10 µM kainate (open bars), or kainate plus
Cd (cyan bars) in HEK cells expressing GluK2(Q) A8C (A) or
GluK2(Q) L10C (B). Note that for the L10C substitution (B),
current evoked by kainate plus Cd was larger than the sum of
current evoked by kainate alone (black arrow) and Cd alone
(red arrow). (C) Currents evoked by Cd alone and kainate plus
Cd in the same cell plotted as a fraction of the current evoked
by kainate alone for GluK2 A8C with either 5 µM Cd (open
symbols, 10 cells for Q) or 50 µM Cd (20 cells; 13 for Q and 7
for R) and GluK2 L10C with.50 µM Cd (15 cells; 10 for Q and
5 for R). Results for individual cells are plotted in gray and
connected by lines (open symbols are Q, and solid symbols
are R); larger colored symbols plot mean ± SEM. Note the
y-axis log scale. Asterisk denotes significant difference from
Cd alone (P < 0.00003, paired t test).

B and C, and see below); however, inhibition of mutant receptors
exhibited substantially weaker potency than for homomeric WT
receptors (Fig. 2 and Table 1).
A8C and L10C substitutions increase agonist potency
Previous work has shown that inner helix mutations, including
A8 substitutions (Kohda et al., 2000; Taverna et al., 2000; Klein
and Howe, 2004), can increase iGluR agonist potency, highlighting the mechanistic linkage between agonist binding to the LBD
and conformational changes at the bundle crossing. To determine
whether A8C and/or L10C substitutions affected agonist potency
at GluK2, we recorded currents evoked by 2.5 nM to 160 µM kainate in cells transfected with GluK2(Q) A8C, GluK2(R) A8C, and
GluK2(Q) L10C. As shown in Fig. 5, kainate was >10-fold more
potent at receptors with A8C or L10C substitution as compared
with WT (Jones et al., 1997; Wilding et al., 2005). Indeed, the
concentration dependence for all three constructs was similar
enough that individual fits to data for each one alone were not
statistically superior to a simultaneous fit of all three data sets
with an EC50 = 120 ± 9 nM (F test; Fig. 5).
In addition to recording currents evoked by kainate alone,
we also evaluated currents elicited by kainate together with a
low dose of Cd (Fig. 5), either 50 µM for the L10C substitution or
0.5 µM for the A8C substitution. These values were chosen near
the “foot” of the respective concentration–response relations
for current activation by Cd alone (Fig. 4). For receptors with
the L10C substitution, adding 50 µM Cd caused an ∼4.5-fold increase in kainate potency (EC50 = 26 ± 3 nM); however, for the
A8C substitution, adding 0.5 µM Cd caused no significant change
in EC50 for activation by kainate (Fig. 5 C). In addition, for the
A8C substitution, we did not observe evidence for synergy between 10 µM kainate and submaximal doses of Cd (0.5 or 5 µM).
Currents evoked by coapplication of kainate and 0.5 or 5 µM Cd
in cells expressing GluK2 A8C were less than or equal in amplitude to the sum of current evoked by kainate alone and Cd alone
(Fig. 6, A and C), whereas for L10C, coapplication of kainate plus
Cd evoked current that was larger than the sum of current elicited by kainate alone and Cd alone (Fig. 6, B and C).
To determine whether the increase in agonist potency observed for receptors with M3 Cys substitutions (Fig. 5) was
somehow required for activation by Cd, we added an E to D subWilding and Huettner
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stitution in the LBD (E738D) that was previously found to reduce
agonist potency (Mah et al., 2005). As shown in Fig. S1, current
activation by 50 µM Cd alone persisted in the GluK2(Q) A8C
E738D double mutant despite a substantial reduction in kainate
potency (EC50 = 28 ± 5 µM). Thus, Cd activation is not restricted
to receptors with higher agonist affinity. Indeed, the ∼230-fold
change in EC50 from 120 nM for K2(Q) A8C to 28 µM for K2(Q)
A8C E738D is similar in magnitude to the 270-fold change previously reported for K2(Q) E738D compared with WT GluK2 (Mah
et al., 2005). Based on these agonist EC50 values (Kash et al., 2003;
Gleitsman et al., 2008; Venkatachalan and Czajkowski, 2008), we
estimate a coupling energy (ΔΔG) <100 cal/mol for the A8C and
E738D mutations, suggesting a lack of strong interaction between
the residues at these two positions.
Cd opens the channel
Previous work suggests that iGluRs with amino acid substitutions
at the A8 Lurcher site exhibit lower unitary conductance than
WT receptors (Kohda et al., 2000; Murthy et al., 2012). In addition, editing at the Q/R site reduces conductance of WT GluK2(R)
<1 pS, making it difficult to resolve unitary currents above the
background noise (Howe, 1996; Huettner, 2015). Therefore, to
provide an initial characterization of channel activity promoted
by exposure to Cd, we performed fluctuation analysis (Lopez et
al., 2013) of whole-cell currents evoked by 50 and 500 µM Cd or
10 µM kainate in cells expressing edited (R) receptors with A8C
substitution, as well as currents evoked by 10 µM kainate plus
50 µM Cd in cells transfected with GluK2(Q) L10C (Fig. 7).
For the L10C substitution, most plots of current variance (σ2)
versus mean current (I) followed a parabolic trajectory (Sigworth,
1980): σ2 = i × I – I2/N, where i and N are the estimated unitary
current and number of channel, respectively (Fig. 7 and Table 3).
Cd alone, kainate alone, and Cd plus kainate activated channels
with similar estimated unitary conductance (∼1 pS), and differences in maximal current amplitude between Cd, kainate, and
Cd plus kainate largely reflected differences in open probability:
Po = Imax/(i * N). On average, for GluK2(Q) L10C, the unitary conductance with Cd was at least 80% of that for kainate, while the
ratio of open probability with Cd to kainate (Po Cd/Po K) was 0.4
± 0.1 for 50 µM Cd alone, 1.7 ± 0.5 for 500 µM Cd alone, and 3.9 ±
1.3 for kainate plus 50 µM Cd (Table 3).
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Figure 7. Cd increases open probability. (A) Points show mean current
(bottom) and current variance (top) for whole-cell responses evoked by 50
and 500 µM Cd (dark and bright red, respectively), 10 µM kainate (green), and
10 µM kainate + 50 µM Cd (cyan) in an HEK cell transfected with GluK2(Q)
L10C. Holding potential is −80 mV. (B and C) Plots of current variance versus
mean current evoked by 10 µM kainate, 50 or 500 µM Cd alone, or 10 µM
kainate plus 50 µM Cd in HEK cells expressing homomeric GluK2(Q) L10C (B)
or GluK2(R) A8C (C). Note the variance data in A and B are from the same cell
and plotted on the same variance scale, in A as a function of time and in B as
a function of the mean current values for each time segment. Smooth curves
in B are the best fits of the parabolic equation σ2 = i * I − (I2/N), where σ2 is
variance, I is the mean macroscopic current, i is the unitary current (∼0.1 pA),
N is the number of channels (∼12,000), and maximum Po = Imax/(i * N) (∼0.5).
Smooth curves in C are best straight line fits with slope = i (12 fA for kainate
and 4 fA for 50 and 500 µM Cd).

For the A8C substitution, variance versus mean plots were essentially linear, suggesting a relatively low Po (Lingle, 2006). In
contrast to L10C, the slopes of GluK2 A8C variance versus mean
plots were steeper for responses evoked by kainate than by 50 or
500 µM Cd, indicating a higher unitary conductance for channel
activation by kainate (Fig. 7 and Table 3). Assuming that kainate
and Cd act on the same number of channels, the higher maximal
macroscopic current evoked by Cd reflects an ∼20- to 30-fold
higher open probability as compared with kainate: (Po(Cd)/Po(K))
= (ICd * iK)/(IK * iCd). In contrast, the unitary conductance for Cd
alone was only 30–40% as large as for kainate (Table 3).
Specificity for Cys substitution and occlusion by MTS reagents
Cd and other metal ions can bind directly to Cys side chains
(Holm et al., 1996; Rulíšek and Vondrášek, 1998) suggesting that
Cys residues substituted at A8 or L10 may contribute to a novel
Cd binding site. However, as mentioned above, residue changes
at positions 8 and 10 (Fig. 5), as well as at a number of other M3
locations, can alter receptor properties even without exposure
to metal ions (Kohda et al., 2000; Taverna et al., 2000; Klein and
Wilding and Huettner
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Howe, 2004; Chang and Kuo, 2008), raising the possibility that
conformational changes induced by substitutions in the bundle
crossing might alter the effect of Cd binding elsewhere on the
channel or expose novel cryptic Cd interaction sites that are not
accessible in WT receptors. To determine whether activation by
Cd required A8 replacement with Cys, we tested receptors in
which A8 was substituted with other residues including Ser, Thr,
Phe, and Tyr. As shown in Fig. 8, large inward currents evoked
by exposure to 50 µM Cd alone (Fig. 8 A) or together with 10 µM
kainate (Fig. 8 B) were only observed for receptors with A8C substitution. In addition, at higher doses (500 µM and 5 mM), Cd
alone reduced the holding current and inhibited evoked current
when coapplied with kainate to cells expressing the A8S, T, Y, or
F substitution mutants (Fig. S2).
As a further test of the idea that Cd directly interacts with
the Cys side chain substituted for A8 or L10, we compared the
action of Cd before and after exposure to 100 µM MTSEA, a sulfhydryl-reactive compound that modifies free cysteine residues
to produce a positively charged side chain approximately the size
of lysine (Fountain and North, 2006; Akabas, 2015). For both the
A8C and L10C substitutions, treatment with MTSEA significantly
reduced the amplitude of Cd-evoked current (Fig. 8, C–E). In the
case of GluK2(Q) A8C, there was little effect on current evoked
by kainate alone or on the holding current (Fig. 8 D), whereas
for the L10C substitution, both the holding current and the
current evoked by kainate were increased following exposure
to MTSEA (Fig. 8, C and E). Thus, Cys modification by MTSEA
reduces susceptibility to Cd activation of receptors with A8C or
L10C substitutions.
Cd activation of heteromeric receptors
Homomeric mutant receptors with one M3 helix substitution per
subunit would have a total of four novel introduced cysteines. To
test whether Cys substitutions on all four subunits is required,
we first evaluated the effects of Cd on heteromeric receptors produced in HEK cells cotransfected with mutant GluK2(Q) and WT
GluK5 or GluK1(R). As shown in Fig. 9, cells cotransfected with
either GluK1(R) or GluK5 together with GluK2(Q) A8C or GluK2(Q)
L10C displayed currents that were activated by exposure to Cd
alone as well as enhancement of KA-evoked current by Cd coapplication. Previous work suggests that formation of heteromeric
receptors is strongly favored upon coexpression of GluK2 with
GluK1 or GluK5 (Cui and Mayer, 1999; Wilding et al., 2005; Reiner
et al., 2012); however, the possibility that sensitivity to Cd in these
cells resulted from a minor population of homomeric GluK2(Q)
A8C or L10C is difficult to rule out. Agonist- and Cd-evoked I-V relations displayed inward rectification for cells cotransfected with
mutant GluK2(Q) and WT GluK5 (data not shown), which encodes
a Gln at the Q/R site and does not undergo editing (Traynelis et al.,
2010). In contrast, the I-V relations lacked inward rectification
for cotransfections that included the GluK1(R) subunit (Fig. 9 B),
supporting the heteromeric inclusion of edited GluK1(R) within
Cd-sensitive receptors (Fig. 9, A and C). To provide additional evidence that activation by Cd does not require A8C or L10C substitution on all four subunits within the tetramer, we analyzed
substitution mutants of chimeric subunits that only form functional receptors as coexpressed heteromers (Wilding et al., 2014).
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Table 3. Unitary parameters estimated from fluctuation analysis
Kainate

Cd

Cd

Kainate + Cd

10 µM

50 µM

500 µM

10 + 50 µM

Unitary current (fA)

92 ± 8

83 ± 13

76 ± 11

79 ± 9

Unitary conductance (pS)

1.15 ± 0.10

GluK2(Q) L10C

g Cd/g K

1.04 ± 0.16

0.94 ± 0.14

0.99 ± 0.11

0.93 ± 0.07

0.81 ± 0.05

0.85 ± 0.04

Maximal current (pA)

212 ± 38

75 ± 4

218 ± 18

412 ± 38

Open probability

0.21 ± 0.03

0.09 ± 0.02

0.30 ± 0.05

0.48 ± 0.03

0.4 ± 0.1

1.7 ± 0.5

3.9 ± 1.3

10

8

9

10

Unitary current (fA)

15.7 ± 3.0

4.4 ± 0.9

4.0 ± 0.7

Unitary conductance (fS)

197 ± 37

55 ± 11

50 ± 9

0.39 ± 0.07

0.32 ± 0.08

1,350 ± 300

860 ± 130

27 ± 13

20 ± 6

16

9

Po Cd/Po K
Number of cells
GluK2(R) A8C

g Cd/g K
Maximal current (pA)

473 ± 158

Po Cd/Po K
Number of cells

16

Cys substitutions to chimeric subunits
Because NMDA receptors are obligate heteromers (Traynelis et
al., 2010), chimeric subunits in which the GluK2(Q) TMD and
CTD are linked with the ATD and LBD of GluN1 or GluN2B do not
generate functional channels when expressed alone in HEK cells
but only when coexpressed (Wilding et al., 2014). As shown in
Fig. 10, 50 µM Cd alone activated chimeric receptors with A8C
substitution to either the N2B/K2(Q) (Fig. 10 A) or N1/K2(Q)
(Fig. 10 B) subunit or to both subunits (Fig. 10 C). In contrast, cells
expressing chimeric receptors with WT M3 residues (Fig. 10 D)
and cells transfected with WT GluN1 plus GluN2B (Fig. 10 E)
often displayed small reductions in holding current when exposed to 50 µM Cd alone and partial block of agonist-evoked
current, similar to the effects of Cd on WT GluK2 (Figs. 2 and
3). Fig. 10, F and G, summarize results for WT and A8C mutant
chimeric subunits during exposure to Cd alone (Fig. 10 F) or Cd
plus agonist (Fig. 10 G). When expressed as a fraction of the current evoked by agonist alone, responses to Cd alone or Cd plus
agonist for chimeric receptors with A8C substitution to either
the N1/K2(Q) or N2B/K2(Q) subunit were comparable to homomeric GluK2(Q) A8C and nearly as large as Cd responses observed
for receptors with A8C substitution in both chimeric subunits
(Fig. 10, F and G).
To test for possible differences in potency of Cd activation
among chimeric receptors with either or both subunits bearing
A8C substitutions, we evaluated the currents evoked by additional Cd concentrations. As shown in Figs. 10, A–C, and 11, A and
B, exposure to Cd concentrations up to 50 µM yielded essentially
monotonic current activation at the onset of Cd and monotonic
decay on return to control solution. In contrast, currents elicited
by higher Cd concentrations displayed a multiphasic time course
characterized by an initial spike of inward current followed by
Wilding and Huettner
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decay to a lower steady-state plateau and a prominent tail current on Cd wash out (Fig. 11 B), suggesting a composite response
that includes a component of low-affinity block superimposed on
current activation. For the summary plots in Fig. 11 D, the steadystate currents during Cd exposure are normalized to the maximal
peak inward current recorded at the onset or offset of treatment
with 5 mM Cd. Based on this analysis summarized in Table 1, Cd
activation was more potent at receptors that included A8C substitutions in both chimeric subunits (EC50 = 5.6 ± 1.7 µM) than for
receptors in which A8C was only present in the N2B/K2(Q) subunit (EC50 = 27 ± 9 µM) or the N1/K2(Q) subunit (EC50 = 47 ± 8 µM).
In addition, block by higher Cd concentrations was substantially
weaker for chimeric receptors that only included the A8C substitution to the N1/K2(Q) chimera (IC50 = 13 ± 10 mM; Fig. 11 A) but
significantly more potent for chimeric receptors that included the
N2B/K2(Q)A8C subunit, either alone (Fig. 11 B) or together with
N1/K2(Q)A8C (IC50 = 1.1 ± 0.2 mM; Fig. 11 D). For comparison, we
also evaluated the concentration dependence of Cd inhibition at
WT N1 + N2B NMDA receptors as well as chimeric receptors with
WT M3 residues. As shown in Fig. 12, inhibition observed during
exposure to 10 µM NMDA and glycine was stronger for receptors
lacking the A8C substitution, being half-maximal at 200 µM Cd
for WT NMDA receptors and 400 µM for chimeric receptors.
As for homomeric GluK2 (Fig. 4 A, inset), we also used exponential fits to the monotonic rise and decay of current observed
with exposure to 50 µM Cd to determine the onset and recovery
time constants for current activation (Table 2). Kinetics of inhibition were estimated from the biphasic onset and recovery currents recorded upon exposure to high Cd concentrations, which
were fit with the sum of two exponentials. Fig. 11 C shows an example for chimeric receptors that included N2B/K2(Q)A8C, expanded from the trace in Fig. 11 B, with the onset fit (red curve)
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Figure 9. Cd activates heteromeric kainate receptors. (A) Whole-cell currents evoked by 10 µM kainate (open bars) and 500 or 50 µM Cd alone (red
bars) or together with 10 µM kainate (mauve and cyan bars, respectively) in a
cell cotransfected with GluK2(Q) L10C and GluK1(R). (B) Lack of inward rectification in current–voltage relations from the same cell shown in A supports
formation of heteromeric receptors. (C) Summary plots of current (mean ±
SEM) evoked by 50 µM Cd alone (left; 10–114 cells per construct) or 50 µM
Cd plus 10 µM kainate (right; 9–17 cells) as a fraction of kainate alone in cells
transfected with GluK2(Q) alone or cotransfected with GluK2(Q) A8C or L10C
together with either GluK1(R) or GluK5. Note the log scale. Asterisk denotes
significant difference from homomeric GluK2(Q) A8C or L10C.

Figure 8. Cd sensitivity requires Cys substitution. (A and B) Summary
plots of current (mean ± SEM) evoked by 50 µM Cd alone (A) or 10 µM kainate
plus 50 µM Cd (B) as a fraction of current evoked by 10 µM kainate alone for
A8 substitution with C, S, T, F, or Y. Asterisk denotes significant difference
from S, T, F, or Y (ANOVA on ranks with post hoc Dunn’s test, 5–114 [A] or
3–17 [B] cells per construct). (C) After brief exposure to 100 µM MTSEA (blue
bar) together with 10 µM kainate (open bars), the holding current and current
evoked by 10 µM kainate were increased, whereas current evoked by 50 µM
Cd alone (red bars) or with 10 µM kainate (cyan bars) was reduced. (D and E)
Summary plots of current (mean ± SEM) evoked by Cd alone or with kainate,
by kainate alone, and the holding current after MTSEA as a fraction of current
before MTSEA for GluK2(Q) A8C (D; six cells) or L10C (E; six cells). Asterisk
denotes significant difference from I post = I pre (t statistic, P < 0.01).

providing estimates for the time constant of current activation
(τ1) and block (τ2) and the recovery fit (blue curve) yielding estimates for the time constant of unblock (τ3) and deactivation (τ4).
We used the time constants determined for N1/K2 + N2B/K2 A8C
(Table 2) to construct kinetic models (Fig. S3 and Table 3) that
reproduce several features of Cd activation and block observed for
the three chimeric subunit combinations analyzed in Fig. 11. The
models assume that binding of either one or two Cd ions supports
activation of receptors with A8C substitutions to both the N1/K2
and N2B/K2 subunits, whereas receptors with only one of the two
chimeric subunits bearing an A8C mutation can only bind a single
activating Cd. Inhibition is modeled by independent binding of up
Wilding and Huettner
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to four additional Cd ions to lower-affinity sites. The same set of
rate constants for activation (kon = 17,500 mol−1 s−1, koff = 0.39 s−1),
inhibition (kon = 240 mol−1 s−1, koff = 2 s−1), and channel opening
(β = 50 s−1, α = 200 s−1) define the models for all three construct
combinations: N1/K2 A8C + N2B/K2 (model 1 + 2), N1/K2 + N2B/
K2 A8C (model 1 + 4), and N1/K2 A8C + N2B/K2 A8C (model 2 + 4).
As shown in Fig. 13, current activation by Cd alone and synergy between Cd and kainate was also observed for chimeric receptors with L10C substitutions to either the N1/K2(Q) or N2B/
K2(Q) subunit or both. Comparing the results for receptors with
A8C or L10C substitutions (Figs. 10 F and 13 B) confirmed a significantly larger effect by 50 µM Cd on receptors with Cys substitution to all four chimeric subunits in the tetramer (two-way
ANOVA). For each of the construct combinations, however, post
hoc pairwise comparison indicated no significant difference
in 50 µM Cd effect between the A8C and the L10C substitution
(Student–Newman–Keuls test). Collectively, the results in Figs.
10, 11, 12, and 13 confirm that substitution to all four subunits
in the tetramer is not required for sensitivity to Cd at either the
A8 or L10 positions. In addition, these experiments demonstrate
similar activation by Cd for substitutions to either the N1/K2 or
N2B/K2 chimeric subunits, suggesting nearly symmetrical interaction between subunits in either the A/C or B/D conformations,
respectively (Wilding et al., 2014).
Mutation of potential coordination partners
The apparent potency of Cd activation of receptors with A8C substitutions in the 10–50 µM range (Fig. 10 D) is consistent with Cd
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Figure 10. Cadmium activation of chimeric receptors with A8C substitutions. (A–C) Whole-cell currents evoked by 10 µM NMDA plus 10 µM glycine
(open bars) or by 50 µM Cd alone (red bars) in HEK cells cotransfected with
chimeric subunits bearing A8C substitutions on the N2B/K2(Q) subunit (A),
on the N1/K2(Q) subunit (B), or on both chimeric subunits (C). (D and E) Chimeric receptors lacking cysteine substitution (D) and WT (N1 + N2B) NMDA
receptors (E) were not activated by Cd alone, and coapplication of Cd (cyan
bars) inhibited agonist-evoked current. (F and G) Summary plots of current
evoked by Cd alone (F; 9–114 cells per construct) or together with agonists (G;
6–17 cells) as a fraction of the current evoked by agonists alone (mean ± SEM).
The first four positions plot results for chimeric receptors. For comparison,
GluK2(Q) WT and A8C results are replotted from Fig. 1 followed by WT GluN1 +
GluN2B. Note the y-axis log scale. Asterisk denotes significantly greater effect
of 50 µM Cd on receptors with A8C substitution to both chimeric subunits
(one-way ANOVA with post hoc Student–Newman–Keuls test), # indicates
significant inhibition of kainate-evoked current by Cd (t statistic), and ns indicates no significant increase in holding current by Cd alone (t statistic).

coordination by two or more side chains (Puljung and Zagotta,
2011; Zhou et al., 2015). The most likely coordination partners include His, Glu, Asp, or other Cys residues (Rulíšek and Vondrášek,
1998), although interactions involving other polar residues as
well as backbone carbonyls are also possible. To test for potential
coordination partners, we have begun making substitutions to
Wilding and Huettner
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Figure 11. Concentration dependence of chimeric A8C mutant receptor
activation. (A and B) Whole-cell currents evoked by Cd (5 and 1 mM and 500,
50, 5, and 0.5 µM) in cells transfected with N1/K2 A8C + N2B/K2 (A) or N1/
K2 + N2B/K2 A8C (B). Chimeric receptors were both activated and blocked
by the highest Cd doses tested, with stronger block observed for channels
that included the N2B/K2 A8C subunit (B). (C) Currents from the onset and
termination of 5 mM Cd exposure in B shown on an expanded time scale and
fit with the sum of two exponentials (superimposed smooth curves). Exposure onset (red curve) includes time constants for activation (τ1 = 50 ms) and
onset of block (τ2 = 0.2 s). On return to control solution (blue curve), receptors
unblock (τ3 = 0.5 s) and deactivate (τ4 = 8 s). (D) Plot of steady-state current
(mean ± SEM) during exposure to Cd as a fraction of the maximal Cd-evoked
response, usually the peak tail current at termination of exposure to 5 mM Cd.
Smooth curves are the best fit of (Materials and methods) I/Imax = m + ((1/(1 +
(EC50/[Cd])n) − m)/(1 + ([Cd]/IC50)b)). For N1/K2A8C + N2B/K2 (blue triangles;
14 cells) the EC50 = 47 ± 8 µM, n = 1.0 ± 0.2, IC50 = 13 ± 10 mM, b = 0.9 ± 0.4,
and the minimum parameter (m) was set to zero. Curves for N1/K2 + N2B/
K2A8C (red inverted triangles; 14 cells) and N1/K2A8C + N2B/K2A8C (violet
squares; 21 cells) show simultaneous fits constrained to have the same IC50 =
1.1 ± 0.2 mM, b = 1.8 ± 0.4, n = 0.9 ± 0.1, and m = −0.43 ± 0.12 with different
EC50 values 27 ± 9 µM and 5.6 ± 1.7 µM, respectively. Individual fits requiring
three additional free parameters were not significantly better (F test).

likely candidate residues that are located near the A8 position in
GluK2 homology models (Lopez et al., 2013) and cryo-EM structures
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Figure 12. Cd inhibits chimeric and WT NMDA receptors. (A and B)
Whole-cell currents evoked by 10 µM NMDA and 10 µM glycine (open bars)
in HEK cells transfected with GluN1wt and GluN2Bwt cDNA (A) or with N1/
K2(Q) and N2B/K2(Q) cDNA (B). Cd was coapplied at 3.2, 16, 80, or 400 µM
or at 2 or 10 mM as indicated by the solid bars. (C) Current (mean ± SEM)
recorded during Cd coapplication as a fraction of control current immediately
before Cd exposure (six WT and eight chimera cells). Smooth curves are the
best fit of I/Icontrol = m + (1 − m)/(1 + ([Cd]/IC50)n).

(Meyerson et al., 2016). There are no His residues near the GluK2
bundle crossing; therefore, our initial experiments focused on
three negatively charged Glu residues in the S2–TMD linkers
within 15 Å of the A8C side chain, as well as two Cys residues
slightly farther away in the M1 helix. The plots in Fig. 14 show
that activation by Cd persisted in receptors where these residues
have been replaced individually or in combinations. Collectively,
these results demonstrate that coordination of Cd between A8C
and any of these side chains is not required for activation.
Instead, coordination may involve neutral polar side chains,
backbone carbonyl groups, or negatively charged residues
more distant than 15 Å in currently available structures. Alternatively, Cd might coordinate between the substituted A8C side
chains, although this would position Cd along the pore axis,
which might be expected to impede ion flux (Discussion). Additional experiments will be needed to determine which of these
various alternatives underlies coordination responsible for activation of A8C mutants by Cd.
Wilding and Huettner
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Figure 13. Cd activation of chimeric receptors with L10C substitutions.
(A) Whole-cell currents activated by 10 µM NMDA plus 10 µM glycine (open
bars) or 50 µM, 500 µM, or 5 mM Cd alone (red bars) or together with agonist
(cyan bars). (B) Current (mean ± SEM) evoked by Cd alone (left; 5–15 cells
per construct) or agonist plus Cd (right; 5–14 cells) as a fraction of current
evoked by 10 µM NMDA plus 10 µM glycine. Note the y-axis log scale. Asterisk denotes significantly greater effect for receptors with L10C substitution
to both chimeric subunits at each Cd dose (one-way ANOVA with post hoc
Student–Newman–Keuls test), # indicates significant inhibition of kainate-evoked current by Cd (t statistic), and ns indicates no significant increase
in holding current by Cd alone (t statistic).

Discussion

Recent work on iGluR gating has focused on the LBD–TMD linkers
and the extracellular ends of the M1, M3, and M4 helices as loci
for disease-causing mutations (Guzmán et al., 2017; Fry et al.,
2018) and as targets for iGluR subtype-selective allosteric modulators (Yelshanskaya et al., 2016; Wang et al., 2017; Perszyk et
al., 2018). The recognized importance of this region for control
of channel gating has fueled recent mutagenesis work analyzing
the structural requirements for mechanical coupling between
the LBD and TMD (Alsaloum et al., 2016; Yelshanskaya et al., 2017;
Ladislav et al., 2018). In the present study, we have identified two
positions near the extracellular end of the M3 helix where cysteine substitution renders GluK2 kainate receptors susceptible to
direct activation by exposure to Cd. One site is homologous to the
location of the A8T point mutation in the iGluR delta subunit of
Lurcher mice (Zuo et al., 1997; Kohda et al., 2000). The other site
is a leucine located two residues farther along the M3 helix (L10),
a rotation of 200° around the helical axis (Fig. 15 A). Our experiments demonstrate that strong activation by Cd is specific to Cys
substitution and that exposure to Cys-reacting MTS reagents can
occlude the effects of Cd. These results provide evidence that the
introduced Cys residues directly interact with Cd but do not resolve whether coordination by additional side chains is required
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Figure 14. Potential coordination partners not required
for Cd activation. (A) Whole-cell current 10 µM kainate (open
bars), 50 µM Cd alone (red bar), and 5 or 50 µM Cd together
with kainate (cyan bars) in an HEK cell transfected with triple
mutant GluK2(Q) A8C, E13A (in the M3–S2 linker), and E811A (in
the S2–M4 linker). (B and C) Summary plots of current (mean
± SEM) evoked by Cd alone (B; 4–114 cells per construct) or Cd
plus kainate (C; 4–17 cells) as a fraction of the current evoked by
kainate alone (note the y-axis log scale).

for channel activation. The difference in potency for Cd activation of channels with A8C or L10C substitutions suggests that distinct mechanisms may be involved. The EC50 values in the range
of 5–10 µM that we observed for receptors with A8C substitutions on all four subunits are consistent with a Cd binding site involving at least two coordinating residues (Puljung and Zagotta,
2011), whereas the weaker potency for activation of homomeric
GluK2(Q) L10C (EC50 ∼2 mM) suggests that tight coordination by
multiple residues is not required for Cd activation of channels
bearing this mutation. For the L10C substitution, channel modification by MTSEA occluded activation by Cd but also produced
changes that were similar to the effects observed during Cd exposure, including a substantial increase in the holding current
as well as in kainate-evoked current. This result suggests that
addition of positive charge at this location, which could serve to
destabilize hydrophobic bundle crossing occlusion, has a similar
effect on channel properties whether it results from the Cys side
chain binding Cd or undergoing covalent modification by MTS
EA. In contrast, for the A8C substitution, MTSEA occluded the
action of Cd without significant change in holding current or activation by kainate, suggesting that addition of positive charge
alone is not sufficient at this location and coordination by multiple residues may be necessary.
Previous work (Rulíšek and Vondrášek, 1998) indicates a bond
length of ∼2.6 Å between Cd ions and the terminal sulfur of Cys
side chains, suggesting that other coordination partners would
need to be relatively close to the A8C or L10C positions, at least
in the Cd-bound activated state. Analysis of metal ion binding
sites across a wide array of proteins (Holm et al., 1996; Rulíšek
Wilding and Huettner
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and Vondrášek, 1998) suggests that the most likely coordination
partners include histidine (Holmgren et al., 1998) or other free
cysteine residues (Liu et al., 1997; Sobolevsky et al., 2002), as
well as negatively charged glutamate or aspartate (Veran et al.,
2012; Zhou et al., 2015), and with lower-frequency polar serine,
threonine, or tyrosine residues or backbone carbonyls (Holm et
al., 1996; Rulíšek and Vondrášek, 1998). As an initial screen for
potential coordination partners, we generated substitutions
that replaced Cys residues in the M1 helix or negatively charged
Glu side chains in the M3–S2 and S2–M4 linkers within 15 Å of
A8C; however, these changes failed to eliminate Cd activation of
GluK2(Q) A8C, suggesting that these residues are not essential
for direct coordination of Cd. Conformational changes associated with channel opening by Cd might bring other possible coordination partners within closer proximity of the A8C or L10C
substitutions, but further experiments will be needed to determine whether any other residues more distant from the A8C or
L10C are required.
Our results with heteromeric kainate receptors and receptors formed by coexpression of chimeric subunits demonstrate
that activation by Cd does not require Cys substitution to all four
subunits in the tetramer, although for the A8C substitution, Cd
potency was shown to be lower for receptors with fewer M3 A8C
replacements. Cd activated chimeric receptors with A8C substitutions in both the N1/K2 and N2B/K2 subunits with an EC50
of ∼6 µM, which was similar to the EC50 of 10 µM observed for
homomeric GluK2 A8C. In contrast, Cd was ∼5- to 10-fold less
potent for activation of chimeric receptors in which the A8C
substitution was only present on the N2B/K2 (EC50 = 27 µM) or
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Figure 15. The M3 helix positions that support activation by Cd. (A) The
M3 helical wheel from isoleucine (−1) to glutamate (+13). Circle diameters proportional to side chain volume. Colors denote side chain properties: negative
charge (red), polar (blue), aromatic (green), hydrophobic (black), and cysteine
substitution at positions 8 and 10 (yellow). (B) Semitransparent view down
the open state model TMD axis illustrating A7, A8C, and L10 side chains. (C)
The TMD side view of two GluK2 A8C open state homology model subunits in
the C (blue) and D (yellow) conformations rotated 90° from B. The A7, A8C, and
L10 side chains are shown as sticks. Vertical gray arrow denotes the central
axis with the backbone cartoon semitransparent. A higher-resolution view of
the boxed region is shown on the right.

the N1/K2 (EC50 = 47 µM) subunit. Given that WT receptors show
no activation for up to 5 mM Cd, we estimate a coupling energy
(ΔΔG) of at least 3 kT (∼1.9 kcal/mol) for A8C substitution of the
two chimeric subunits.
Our numerical simulations suggest that relatively simple kinetic models are at least qualitatively consistent with activation
and inhibition of chimeric receptors by Cd. The models include
channel activation by binding one or two Cd ions depending on
whether the A8C substitution was present on one or both of the
GluN/GluK2 chimeric subunits, whereas inhibition results from
two or four additional lower-affinity Cd binding steps. In the
present case, state transitions in all of the models were defined
by the same set of four rate constants, which corresponds to an
assumption that all interactions are symmetrical and independent. Further simulations may provide a better quantitative fit to
experimental recordings by modifying individual rate constants
to incorporate positive or negative cooperativity between the
various binding steps or to reflect possible asymmetry between
A8C substitution to the N1/K2 or N2B/K2 chimeric subunits.
From previous work on block of GluA1 A7C AMPA receptors
it has been suggested that metal ions can coordinate between introduced M3 Cys residues on adjacent subunits (Sobolevsky et al.,
2004). Although this might explain Cd interaction with receptors
that have Cys substitution in all four subunits of the tetramer,
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it seems less likely to hold for heteromeric combinations with
Cys substitution on only two of the four subunits. In particular,
the N1–N2–N1–N2 alternating arrangement of native NMDA
receptors (Salussolia et al., 2011; Riou et al., 2012; Karakas and
Furukawa, 2014; Lee et al., 2014) predicts that our heteromeric
chimeric receptors with A8C or L10C substitution in only the N1/
K2 or only the N2B/K2 subunit would not present Cys residues on
adjacent subunits but instead introduce Cys side chains displayed
diagonally across the central axis with a separation distance of
12–14 Å in currently available closed and open state structures
(Sobolevsky et al., 2009; Meyerson et al., 2016; Chen et al., 2017;
Twomey et al., 2017). Although we cannot rule out coordination
across the diagonal between Cys substitution to subunits in the
A and C conformation (N1/K2 chimera) or the B and D conformation (N2B/K2 chimera), such a mechanism would appear to
require substantial M3 reorientation and would locate the coordinated Cd ion directly along the central axis.
Recent work on the presumed open conformation of homomeric GluA2 AMPA receptors (Chen et al., 2017; Twomey et al.,
2017) has described substantial deformations in the M3 helix of
subunits in the B and D conformation with more limited changes
to the A and C subunits. In particular, the M3 helix remains
straight in the open state A and C conformations, whereas the B
and D subunits exhibit a notable kink at the A4 position (Chen et
al., 2017; Twomey et al., 2017), which precedes the A8C and L10C
substitutions studied here. Fig. 15, B and C, depict axial and side
views of a GluK2 A8C homology model based on the AMPA receptor open state structure. The A8C side chains reside closer to the
pore axis than L10, which may contribute to the lower conductance ratios (g Cd/g K) observed for Cd bound to A8C compared
with L10C. Although it remains to be determined whether M3
helix structural deformations occur in the open states of homomeric GluK2 or the GluN/GluK2 chimeric subunits, the modest
functional asymmetry we observe for Cd activation and inhibition of A8C and L10C substitutions to N1/K2 or N2B/K2, together
with the lower estimated unitary conductance for channels activated by Cd, suggest that the open states induced by Cd binding
may be distinct from the native open conformation.
In contrast to cells transfected with WT GluK2, some of the
cells expressing WT N1 + N2B or chimeric subunits with WT M3
residues displayed a reduction in holding current or inhibition
beyond the initial holding level during exposure to millimolar
Cd. For receptors bearing mutations that destabilize the bundle
crossing, this effect at high Cd concentrations probably reflects
inhibition of constitutive current mediated by the transfected
receptors in the nominal absence of agonist. Our previous work
(Wilding et al., 2014) showed that activation of receptors formed
by chimeric subunits lacks the tight requirement for occupation
of both NMDA and glycine sites observed with full-length WT
subunits (Traynelis et al., 2010), suggesting that stray levels of
glycine may be sufficient for chronic partial activation of chimeric receptors (Wilding et al., 2014). For cells transfected with WT
NMDA receptor subunits, it remains to be determined whether
all of the current blocked by millimolar Cd is mediated directly by
NMDA receptors or whether expression of these receptors may
enhance other Cd-sensitive currents, possibly by persistent elevation of cytoplasmic calcium levels.
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Conclusions

Increasing evidence implicates a role for kainate receptors in
nociception (Bhangoo and Swanson, 2013) and neural development (Guzmán et al., 2017) as well as neuropathologies including epilepsy (Crépel and Mulle, 2015) and psychiatric disorders
(Lerma and Marques, 2013). Better understanding of how these
receptors operate should aid in the design of therapeutic agents.
Our experiments demonstrate that Cd binding can directly
open channels with Cys substitutions at two positions near the
inner helix bundle crossing, circumventing the requirement
for agonist site occupation. At one of the sites (L10C), Cd binding acts synergistically with agonist, and tight coordination of
Cd is not required. In contrast, we saw no evidence for synergy
with agonist for channel activation by Cd coordination at the
A8C substitution two residues preceding L10. The A8 position is
homologous to the delta subunit residue where gain of function
mutations produce cerebellar ataxia both in humans (Coutelier
et al., 2015) and in the Lurcher mutant mouse strain (Zuo et al.,
1997). More recently, de novo A8T mutation in human GRIK2,
which encodes the GluK2 subunit, was shown to underlie a set
of human neurodevelopmental deficits including ataxia and intellectual disability (Guzmán et al., 2017). Additional work on M3
helix substitutions should help further elucidate the conformational changes that mediate iGluR gating in health and disease.
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Figure S1. Cd activation does not require increased agonist potency. (A) Whole-cell currents evoked by 100 µM kainate (open bars) or 50 µM Cd (red
bars) in cells transfected with GluK2(Q) A8C and GluK2(Q) A8C E738D. (B) Current (mean ± SEM) evoked by 50 µM Cd as a fraction of 100 µM kainate for
GluK2(Q) A8C (open bar; 9 cells) and GluK2(Q) A8C E738D (solid bar; 37 cells). (C) Plots of normalized kainate-evoked current (mean ± SEM) for GluK2(Q) A8C
E738D (solid squares; 15 cells), as well as GluK2(Q) A8C (open squares) and GluK2(R) WT (open circles) from Fig. 5. The EC50 for GluK2(Q) A8C E738D of 28 ±
5 µM (n = 1.6 ± 0.2) indicates potency 233-fold lower than for GluK2(Q) A8C (EC50 = 120 nM).
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Figure S2. Cd inhibits GluK2 A8S, T, Y, or F. (A) Whole-cell current evoked by 10 µM kainate (open bars) was inhibited by Cd coapplication (cyan bars), and
increasing concentrations of Cd alone (red bars; 50 µM, 500 µM, and 5 mM Cd) produced a dose-dependent reduction in the holding current in an HEK cell
transfected with GluK2(R) A8T. (B and C) Summary plots of current (mean ± SEM) recorded during exposure to Cd alone (B) or Cd plus kainate (C) as a fraction of current evoked by kainate alone for homomeric receptors with S, T, F, or Y substitution at A8 (4–30 cells per construct).
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Figure S3. Kinetic models for Cd activation and inhibition. (A) Schemes for activation by one Cd and inhibition by two Cd (1 + 2), activation by one Cd
and inhibition by four Cd (1 + 4), and activation by two Cd and inhibition by four Cd (2 + 4). Rate constants for activation (k1, k2) and block (k3, k4) were
chosen for the 1 + 4 scheme to approximate the time constants observed with the N1/K2 + N2B/K2 A8C chimera for activation by 50 µM Cd and inhibition
by 5 mM Cd, respectively (Table 2). Rates for opening and closing (β, α) were set to yield a maximal open probability of 0.2 (Fig. 7). Solution exchange was
assumed to occur with a time constant of 0.1 s for both onset and recovery. (B and C) Numerical simulations of open probability as a function of time for 10 s
exposure to increasing concentrations of Cd and 20 s recovery for scheme 1 + 4 (B) or schemes 2 + 4 (C; black traces) and 1 + 2 (C; light blue traces). Note that
the same rate constants were used for all three schemes. Red and dark blue lines show single exponential fits to the activation and recovery phases for 50 µM
Cd and sums of two exponentials fit to the onset (red) and recovery (blue) phases for exposure to 5 mM Cd. (D and E) Plots of activation at the end of 10 s
Cd exposure as a function of Cd concentration. In D, the points are normalized to the maximal Po as in Fig. 11; E plots the raw steady-state Po values for the
three schemes. Smooth curves in D are best fits of I/Imax = (1/(1 + (EC50/[Cd])n)/(1 + ([Cd]/IC50)b)). The same equation multiplied by a scaling factor was fit in
E. Table S1 presents fit parameters for the numerical simulations to allow comparison with experimental results in Tables 1 and 2.
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Table S1. Parameters derived from kinetic model simulations
Scheme

Activation (s)
Tau on

Tau off

2+4

0.74

3.92

0.05

2.98

5

1+2

0.96

3.23

0.05

0.04

3.13

5

1+4

[Cd] (mM)

Tau on

[Cd] (mM)

0.98

3.24

0.05

3.32

5

0.26

EC50 (µM)

Slope, n

IC50 (mM) Slope, b

6.5

1.3

2.0

1.6

13.8

1.2

5.0

1.4

12.4

1.3

2.3

1.8

Tau off

0.05

0.04
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Inhibition (s)

0.96

5

0.31

0.53

5

0.25

0.68

5
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